Medgenics Director Unloads $528,000 in Stock (MDGN)
Medgenics (NASDAQ:MDGN) Director Andrew Pearlman unloaded 80,000 shares of the company’s stock on the open market in a transaction dated Thursday, January 9th. The stock was sold at an average price of $6.60, for a total value of $528,000.00. Following the completion of the sale, the director now directly owns 40,562 shares in the company, valued at approximately $267,709. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Medgenics (NASDAQ:MDGN) traded up 2.36% on Friday, hitting $6.95. The stock had a trading volume of 109,661 shares. Medgenics has a 1-year low of $3.50 and a 1-year high of $8.01. The stock has a 50-day moving average of $6.25 and a 200-day moving average of $5.57. The company’s market cap is $127.9 million.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.